Vanderlocht J[au] - Search Results

Year	Number of Results
2003	1
2005	1
2006	4
2007	2
2008	3
2009	2
2010	6
2011	3
2013	3
2014	4
2015	5
2016	3
2017	3
2018	4
2019	3
2020	1
2021	1
2022	1

1

Assessing the feasibility and effectiveness of household-pooled universal testing to control COVID-19 epidemics.

Libin PJK, Willem L, Verstraeten T, Torneri A, Vanderlocht J, Hens N. Libin PJK, et al. Among authors: vanderlocht j. PLoS Comput Biol. 2021 Mar 9;17(3):e1008688. doi: 10.1371/journal.pcbi.1008688. eCollection 2021 Mar. PLoS Comput Biol. 2021. PMID: 33690626 Free PMC article.

2

Natural killer cells: the secret weapon in dendritic cell vaccination strategies.

Van Elssen CH, Oth T, Germeraad WT, Bos GM, Vanderlocht J. Van Elssen CH, et al. Among authors: vanderlocht j. Clin Cancer Res. 2014 Mar 1;20(5):1095-103. doi: 10.1158/1078-0432.CCR-13-2302. Clin Cancer Res. 2014. PMID: 24590885 Free article. Review.

3

Detection of Anti-neutrophil Cytoplasmic Antibodies (ANCA) by Indirect Immunofluorescence.

van Beers JJBC, Vanderlocht J, Roozendaal C, Damoiseaux J. van Beers JJBC, et al. Among authors: vanderlocht j. Methods Mol Biol. 2019;1901:47-62. doi: 10.1007/978-1-4939-8949-2_4. Methods Mol Biol. 2019. PMID: 30539567

4

PIRCHE-II Is Related to Graft Failure after Kidney Transplantation.

Geneugelijk K, Niemann M, Drylewicz J, van Zuilen AD, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Hack CE, van Reekum FE, Verhaar MC, Kamburova EG, Bots ML, Seelen MAJ, Sanders JS, Hepkema BG, Lambeck AJ, Bungener LB, Roozendaal C, Tilanus MGJ, Vanderlocht J, Voorter CE, Wieten L, van Duijnhoven EM, Gelens M, Christiaans MHL, van Ittersum FJ, Nurmohamed A, Lardy JNM, Swelsen W, van der Pant KA, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma A, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG, Spierings E. Geneugelijk K, et al. Among authors: vanderlocht j. Front Immunol. 2018 Mar 5;9:321. doi: 10.3389/fimmu.2018.00321. eCollection 2018. Front Immunol. 2018. PMID: 29556227 Free PMC article. Clinical Trial.

5

A prospect on the use of antiviral drugs to control local outbreaks of COVID-19.

Torneri A, Libin P, Vanderlocht J, Vandamme AM, Neyts J, Hens N. Torneri A, et al. Among authors: vanderlocht j. BMC Med. 2020 Jun 25;18(1):191. doi: 10.1186/s12916-020-01636-4. BMC Med. 2020. PMID: 32586336 Free PMC article.

6

The ambivalent nature of T-cell infiltration in the central nervous system of patients with multiple sclerosis.

Vanderlocht J, Hellings N, Hendriks JJ, Stinissen P. Vanderlocht J, et al. Crit Rev Immunol. 2007;27(1):1-13. doi: 10.1615/critrevimmunol.v27.i1.10. Crit Rev Immunol. 2007. PMID: 17430093 Review.

7

The Maastricht Transplant Center: clinical setting and epitope searches in HLA class II molecules: does the structural localization of a polymorphic site contribute to its immunogenicity?

Schellekens J, Vanderlocht J, Groeneweg M, Voorter CE, Wieten L, Gelens MA, van Duijnhoven EM, van Heurn LW, Christiaans MH, Tilanus MG. Schellekens J, et al. Among authors: vanderlocht j. Transpl Immunol. 2014 Oct;31(4):213-8. doi: 10.1016/j.trim.2014.09.002. Epub 2014 Sep 21. Transpl Immunol. 2014. PMID: 25240735 Review.

8

Characterization of BAT activity in rats using invasive and non-invasive techniques.

Paulus A, van Ewijk PA, Nascimento EBM, De Saint-Hubert M, Hendrikx G, Vogg A, Pooters I, Schnijderberg M, Vanderlocht J, Bos G, Brans B, Schrauwen-Hinderling VB, Mottaghy FM, Bauwens M. Paulus A, et al. Among authors: vanderlocht j. PLoS One. 2019 May 15;14(5):e0215852. doi: 10.1371/journal.pone.0215852. eCollection 2019. PLoS One. 2019. PMID: 31091250 Free PMC article.

9

Antigen-Specific Detection of Autoantibodies Against Myeloperoxidase (MPO) and Proteinase 3 (PR3).

Vanderlocht J, van Beers JJBC, Limburg PC, Damoiseaux J, Roozendaal C. Vanderlocht J, et al. Methods Mol Biol. 2019;1901:153-176. doi: 10.1007/978-1-4939-8949-2_12. Methods Mol Biol. 2019. PMID: 30539575

10

Pathogen-Associated Molecular Patterns Induced Crosstalk between Dendritic Cells, T Helper Cells, and Natural Killer Helper Cells Can Improve Dendritic Cell Vaccination.

Oth T, Vanderlocht J, Van Elssen CH, Bos GM, Germeraad WT. Oth T, et al. Among authors: vanderlocht j. Mediators Inflamm. 2016;2016:5740373. doi: 10.1155/2016/5740373. Epub 2016 Feb 11. Mediators Inflamm. 2016. PMID: 26980946 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results